南六 6504 - 股息配發率

現金殖利率: 2.7%、總殖利率: 2.7%、5年平均現金配發率: 67.63%
要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)

	EPS YoY		現金股利 YoY		現金配發率 YoY		全部配發率 YoY
2025 (5)	-1.09	0	1.00	0.0	0.00	0	0.00	0
2024 (4)	1.39	-15.76	1.00	-9.09	71.94	7.91	71.94	7.91
2023 (3)	1.65	106.25	1.10	10.0	66.67	-46.67	66.67	-46.67

每股盈餘-近8季

	EPS QoQ YoY			本業EPS QoQ YoY			累計EPS QoQ YoY
26Q1 (8)	0.10	-90.57	-83.05	0.48	6.67	77.78	0.10	109.17	-83.05
25Q4 (7)	1.06	116.33	-6.19	0.45	1225.0	80.0	-1.09	49.3	-178.42
25Q3 (6)	0.49	115.17	177.78	-0.04	-108.33	-117.39	-2.15	18.56	-926.92
25Q2 (5)	-3.23	-647.46	-3488.89	0.48	77.78	192.31	-2.64	-547.46	-396.63
25Q1 (4)	0.59	-47.79	0.0	0.27	8.0	0.0	0.59	-57.55	0.0
24Q4 (3)	1.13	279.37	0.0	0.25	8.7	0.0	1.39	434.62	0.0
24Q3 (2)	-0.63	-600.0	0.0	0.23	144.23	0.0	0.26	-70.79	0.0
24Q2 (1)	-0.09	0.0	0.0	-0.52	0.0	0.0	0.89	0.0	0.0

年/月	營收	月增率(%)	去年同期年增率(%)	累計營收	累計營收年增率(%)	近三月累計營收	存貨銷售比	備註(年增率變動50%需說明原因)
2026/4	5.95	-2.73	4.3	21.86	-2.42	16.21	N/A	-
2026/3	6.39	65.0	9.38	16.18	-3.08	16.18	0.54	-
2026/2	3.87	-34.64	-27.59	9.79	-9.79	15.33	0.57	-
2026/1	5.92	6.92	7.47	5.92	7.47	17.21	0.51	-
2025/12	5.54	-3.67	-14.32	66.15	-1.5	17.09	0.5	-
2025/11	5.75	-0.77	-4.86	60.61	-0.13	17.35	0.49	-
2025/10	5.8	-0.18	-9.51	54.86	0.38	16.77	0.51	-
2025/9	5.81	12.45	-6.79	49.06	1.7	16.12	0.53	-
2025/8	5.16	0.28	-7.68	43.25	2.96	15.25	0.56	-
2025/7	5.15	4.29	1.95	38.09	4.59	15.69	0.55	-
2025/6	4.94	-11.88	4.71	32.94	5.02	16.24	0.5	-
2025/5	5.6	-1.75	-10.31	28.0	5.07	17.15	0.47	-
2025/4	5.7	-2.35	-5.58	22.4	9.78	16.89	0.48	-
2025/3	5.84	9.22	14.64	16.7	16.25	16.7	0.51	-
2025/2	5.35	-2.98	37.68	10.86	17.13	17.15	0.5	-
2025/1	5.51	-12.44	2.31	5.51	2.31	17.85	0.48	-
2024/12	6.29	4.13	22.89	66.98	8.4	18.75	0.46	-
2024/11	6.05	-5.62	15.08	60.69	7.09	18.68	0.46	-
2024/10	6.41	2.81	6.55	54.64	6.28	18.23	0.47	-
2024/9	6.23	11.37	14.62	48.24	6.24	16.87	0.49	-
2024/8	5.59	10.75	7.55	42.01	5.1	15.36	0.53	-
2024/7	5.05	7.11	23.94	36.42	4.74	16.01	0.51	-
2024/6	4.71	-24.53	-0.38	31.37	2.19	17.0	0.45	-
2024/5	6.25	3.43	4.21	26.65	2.66	17.38	0.44	-
2024/4	6.04	18.57	7.14	20.4	2.19	15.02	0.51	-
2024/3	5.09	31.17	-7.86	14.36	0.24	14.36	N/A	-
2024/2	3.88	-27.91	-12.88	9.27	5.34	14.39	N/A	-
2024/1	5.39	5.17	24.05	5.39	24.05	15.76	N/A	-
2023/12	5.12	-2.48	7.31	61.79	3.21	16.39	N/A	-
2023/11	5.25	-12.61	-0.32	56.67	2.86	16.7	N/A	-
2023/10	6.01	10.6	-5.08	51.41	3.19	16.65	N/A	-
2023/9	5.43	4.5	-1.91	45.4	4.4	14.71	N/A	-
2023/8	5.2	27.64	1.18	39.97	5.32	14.01	N/A	-
2023/7	4.07	-13.9	-9.62	34.77	5.97	14.8	N/A	-
2023/6	4.73	-21.04	-5.9	30.69	8.46	16.36	N/A	-
2023/5	5.99	6.34	6.54	25.96	11.57	17.16	N/A	-
2023/4	5.64	1.95	20.13	19.97	13.17	15.62	N/A	-
2023/3	5.53	24.02	13.99	14.33	10.65	14.33	N/A	-
2023/2	4.46	2.66	36.2	8.8	8.65	13.57	N/A	-
2023/1	4.34	-9.02	-10.03	4.34	-10.03	14.39	N/A	-
2022/12	4.77	-9.43	-13.54	59.86	-11.75	16.38	N/A	-
2022/11	5.27	-16.78	-17.36	55.09	-11.6	17.14	N/A	-
2022/10	6.33	14.29	6.67	49.82	-10.94	17.01	N/A	-
2022/9	5.54	7.81	2.85	43.49	-13.03	15.19	N/A	-
2022/8	5.14	13.99	13.09	37.95	-14.95	14.68	N/A	-
2022/7	4.51	-10.36	1.3	32.81	-18.13	15.16	N/A	-
2022/6	5.03	-10.6	-9.06	28.3	-20.56	15.35	N/A	-
2022/5	5.63	19.9	-7.03	23.27	-22.67	15.17	N/A	-
2022/4	4.69	-3.25	-20.74	17.64	-26.61	12.82	N/A	-
2022/3	4.85	48.18	-20.18	12.95	-28.53	12.95	N/A	-
2022/2	3.27	-32.18	-36.49	8.1	-32.74	13.62	N/A	-
2022/1	4.83	-12.57	-29.94	4.83	-29.94	16.72	N/A	-
2021/12	5.52	-13.43	-18.73	67.84	-27.6	17.84	N/A	-
2021/11	6.38	7.41	-24.61	62.32	-28.3	17.7	N/A	-
2021/10	5.94	10.2	-37.3	55.94	-28.69	15.87	N/A	-
2021/9	5.39	18.54	-45.44	50.01	-27.51	14.38	N/A	-
2021/8	4.54	2.1	-48.23	44.62	-24.52	14.53	N/A	-
2021/7	4.45	-19.53	-50.57	40.07	-20.38	16.03	N/A	109年防疫產品熱銷，目前平穩
2021/6	5.53	-8.6	-37.15	35.62	-13.81	0.0	N/A	-
2021/5	6.05	2.22	-32.3	30.09	-7.49	0.0	N/A	-